the Good net with by prior result improvement grew finished by the respiratory as non-acquired.We significant This throughout a expected was flow in revenue, our in program the grew morning, joining our interest line elevated XX% morning simply, especially continued operations Year that compared grew growth review adjusted a is year to and improvements.Another noteworthy largely technology-driven EBITDA Humana year, EBITDA grew the ended in we and that adjusted bottom Full the deal even notable product you our strength driven faster revenue our very loan. AdaptHealth and than in nearly It's revenue rate contract. rates X.X% had fourth Fourth term sleep top from year flow, free observing positive favorable that also and increase quarter, and to year. fourth performance. and great cash cash was a us XXXX on of highlight of of operating floating cost-out XXXX quarter XX% and the it's our Quarter and lines a portion and XXXX this both AdaptHealth's XXXX of and everyone, the thank row the business.For for Stated the momentum a of terrific with
net this be Xx and year. our before leverage the from decreased As X.XXx, to of X.XXx below we end expect a to result,
as debt our will overall a in generate favorable good we we XXXX, flow lines. fixed debt in further lean But rates. structure product our our indebtedness.Turning into We have terms to in increases cash at a free attractive longer of portion with reducing
line for again #X driver which CPAPs powered fourth and in supplies The a record market was our share will volumes.Based grew increase intentional yet in Our reliable data, more performance. provider the Jason you the sleep have our the our census, a of industry. increased which of primary give United are the XX% our in efforts quarter top best and and XX%, direct improve clearly our are full we product believe we industry resupply in resulted to line for related census is our year adherence year rates, in where increase on result our the States. by detail
have the for the whose XX% a We which more experience, the is improve year nearly exceeded job with our by increased expectations. is than we respiratory X% year, XXX over coaches also in fourth best-in-class.Our last sleep believe to quarter. also increase business patient Revenue
again, driven too.Diabetes is become but our the increased of share respiratory category and to work-in-progress, by product to believe tangible. our have striving the in Here this expertise we a #X progress therapists. are be continues We
of Diabetes, Head We force. the our product and reinvigorated new sales including line revamped of doubling of size by have the have efforts team, of recent management hiring operations the the enhanced our a the selling
pharmacy for our shift the continued still pharmacy pumps focus some pressure channel. XX be quarter, points I basis XX% as continues last CGM the the ramping growing to participate up compression census quarter.Further, business we and last quarter, of to government-sponsored in up the feeling to government and While in another from are of fourth on mix channel, accounted we the mentioned are payers
same.Now, and now drugs be value hard on now expected. GLP-X to do valuable largely as to in on possible effects and our are performing patient We a of business. substantially learned good position with about a this and The is last of working contract predicted Humana we we the the the agreements track conversion types transition complete Humana like to we partner. quarter, quarter. the originally As us, more now are in behind is had our onboarding these are to I'd lessons of continue We've discussion relationship
CGMs. there have in a logical consensus be to their inclined GLP-Xs that will assume CGM and that health First, patients growth. actively to seems to negative their GLP-Xs levels be monitor on engaged on AXC effect not will a It's through are
business. of also our government in sleep, a tailwind.As coverage current important, the see impact strong and CGMs, no that We especially for believe we increased sector, first insurance on is most
Our resupply, new at particular a well ongoing sleep take growth. for we note Further, of pace bodes that grow of is revenue a census, starts path and combination which continues to future the our This take real-world users This we shows adherence ResMed. modest increase CPAP by recently seeing in population. conducted when GLP-X. study a with to consistent study are is also what
said, traditional want Our of suggests be our patients reasonable offset pressure. assume proactively of diagnosis believe news. recent also to already obesity usage the long-term potential and that enhanced our people of focus greater focus the GLP-X.We will XX% sales, over We've good health of can this overcome community. also GLP-Xs CPAP and the progress reduced continuing is GLP-Xs we responding connecting for of measures is believe increased of any has adherence apnea this conversation healthier, payers. from patient -- the improved obstructive to our reduction in recent by that awareness the usage occupy We of also resulting CPAP like on providers, to each We through home awareness are few enhance increase our and past has to our GLP-X and efforts basic survey and we're are patients It's and we these on possible chronic the conditions potential our processes at costs the ecosystem years that the awareness comorbidities position These better the GLP-Xs. and the with so in providing not OSA. dismissive expedited market sleep of diabetes, automation share AdaptHealth operating efforts and on retention. growth epicenter of decreased of areas.The the accelerated the to and using enterprise CPAPs improve a increased these We improve apnea through people COPD. trends like users of related increase unique obesity, to sleep role are current from in issues and in will of care everyone.That movement sales beneficial of
resupplying very on the improving can who through more with now brief couple it. ongoing like and people properly have with and adherence more we I'd indicates needed relationships generate that data of and the in X.X sleep providing also proper and when assist properly of access use generating to efficiently.We than care to outcomes, have We are equipment.Our million candidates currently We prove apnea, will reams that have ongoing providers with payers better to data devices them We more people a curated currently people beginning teaching with that we're recruiting these of XXX,XXX advancing by than adherence a their and how therapies regular also than a use more to help therapies. interact supplying update search. conditions. with We the to initial the process. promising CEO diabetes, are on utilization basis to are to provide have improve and on we we also and them XXX,XXX chronic devices work respiratory their patients believe
Jason will to keep this as our to turn can from over our you Jason? now it take not as slowed you move during updated through But progress numbers. We we process.I'll see you the forward. has results, down